Trial intelligence / Profile preview

Misoprostol for Cervical Ripening in PROM

NCT02314728Completed

Sponsor
Montefiore Medical Center
Start
Oct 2014
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of misoprostol in premature rupture of membranes (PROM) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Rate of Cesarean Section at 48 hours. Started Oct 2014; status: completed.

02

Drugs

misoprostol
03

Conditions

premature rupture of membranes (PROM)

Beyond the preview

Go deeper on NCT02314728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02314728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call